SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-010489
Filing Date
2022-02-01
Accepted
2022-02-01 18:39:01
Documents
1
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm221371-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm221371-8_4seq1.xml 4 7518
  Complete submission text file 0001104659-22-010489.txt   9107
Mailing Address 414 COMMERCE DRIVE STE 120 FORT WASHINGTON PA 19034
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 D01 H104 (610) 816-6640
Nabriva Therapeutics plc (Issuer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NABRIVA THERAPEUTICS PLC 1000 CONTINENTAL DRIVE, SUITE 600 KING OF PRUSSIA PA 19406
Business Address
Dolan Daniel (Reporting) CIK: 0001826818 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 22580680